News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3 Results
Section
Deals (1)
Drug Development (2)
News (3)
Tag
Clinical research (2)
Mergers & acquisitions (1)
Phase II (2)
Date
2019 (1)
2017 (2)
3 Results for "endologic".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
EndoLogic Announces Feedback From Positive FDA Meeting For Renzapride In Diabetic Gastroparesis
August 9, 2017
·
4 min read
Drug Development
EndoLogic Announces Scheduling Of Pre-IND Meeting With FDA To Discuss Renzapride In Diabetic Gastroparesis
May 3, 2017
·
3 min read
Deals
Atlantic Healthcare plc acquires global rights to renzapride for the treatment of gastrointestinal motility disorders
Renzapride is a clinical stage product, which we believe has wide applicability for the treatment of motility disorders of the gastrointestinal (GI) tract, many of which represent significant unmet medical needs.
June 26, 2019
·
5 min read
